Oral fixed drug eruption due to tinidazole. 2016

Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
Department of Dental Care, Sri Guru Harkrishan Sahib Charitable Eye Hospital, Ludhiana, Punjab, India.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000994 Antitrichomonal Agents Agents used to treat trichomonas infections. Antitrichomonal Drugs,Antitrichomonals,Trichomonicides,Agents, Antitrichomonal,Drugs, Antitrichomonal
D014011 Tinidazole A nitroimidazole alkylating agent that is used as an antitrichomonal agent against TRICHOMONAS VAGINALIS; ENTAMOEBA HISTOLYTICA; and GIARDIA LAMBLIA infections. It also acts as an antibacterial agent for the treatment of BACTERIAL VAGINOSIS and anaerobic bacterial infections. Bioshik,CP-12,574,CP-12574,Fasigin,Fasigyn,Fasigyne,Fasygin,Simplotan,Tricolam,CP 12,574,CP 12574,CP12,574,CP12574

Related Publications

Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
May 1987, JPMA. The Journal of the Pakistan Medical Association,
Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
May 1988, International journal of dermatology,
Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
January 1990, Dermatologica,
Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
January 2006, Indian journal of dermatology, venereology and leprology,
Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
January 1998, Dermatology (Basel, Switzerland),
Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
September 2005, Contact dermatitis,
Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
December 2011, Annals of dermatology,
Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
May 1993, Contact dermatitis,
Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
January 2003, Allergologia et immunopathologia,
Rajbir Singh, and Srinivas S Ramachandra, and Jithendra K Dayakara
April 1997, Contact dermatitis,
Copied contents to your clipboard!